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Abstract: In this work, ratio spectra of the first derivative spectrophotometric and liquid chromatographic methods
have been described for the first time for the simultaneous determination of perindopril (PER), indapamide (IND), and
amlodipine (AML) in dosage forms. For chromatographic separations several mobile phase compositions were tested
for efficient separation with the use of a new column technology related to superficially porous particles. Optimum
chromatographic separation was achieved using a Kinetex C18 column (150 × 4.6 mm I.D. 5 µ m) at a flow rate of
1.5 mL min −1 . The separation was carried out at 30

◦

C and the diode array detector was adjusted to 215 nm. As a

comparison, a spectrophotometric method depending on the first derivative of the ratio spectra was developed. The first
derivative of the ratio amplitudes at 227.2 nm for PER, 269.4 nm for AML, 292.0 nm for IND were selected. The proposed
methods were successfully applied for the simultaneous assay of the drug combination in pharmaceutical dosage forms
and the methods were compared to each other in terms of Student t and F tests for the comparison of their accuracy
and precision parameters.
Key words: Amlodipine, indapamide, perindopril, ratio derivative spectrophotometry, high performance liquid chromatography

1. Introduction
Perindopril (PER) is an angiotensin converting enzyme (ACE) inhibitor used either alone or in combination
in the treatment of hypertension. PER is essentially converted to perindoprilat, which is a prodrug with
hydrolysis. PER is a moderate-action ACE inhibitor suitable for use in one or two daily doses. The drug
blocks the conversion of angiotensin I to angiotensin II. PER is the free acid form of perindopril erbumine; in
vivo, the biologically active metabolite is converted to perindoprilat by hydrolysis of the ester group. Unlike
captopril, perindopril does not contain a sulfhydryl group, which is important for the profile of adverse effects. 1−4
Amlodipine (AML) is a member of the drug class of long-acting dihydropyridine calcium channel blockers used
to treat hypertension and angina pectoris. AML, used in the treatment of hypertension, lowers the body’s
blood pressure by inhibiting calcium entry into the cell through calcium channels in the myocardium and
smooth muscle cell membrane of calcium ions. AML is indicated for the treatment of hypertension and is used
∗ Correspondence:

mgumustas@hotmail.com
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either alone as monotherapy or in combination with other antihypertensive drugs 5−8 Indapamide (IND) is a
benzamide-sulfonamide-indole derived diuretic and antihypertensive drug. Although the exact mechanism of
action related to IND is unknown, it appears that the nephron is mainly effective in the distal tube fold. The drug
inhibits sodium ion transport in kidney tubules, thereby increasing sodium, chloride, and water excretion 9−12
(Scheme).

a

b

c

Scheme. The structures of a) PER, b) AML, c) IND.

Combined drug therapy is based on the coadministration of two or more carefully selected drugs. The
combination of PER/IND/AML is used for the treatment of arterial hypertension. 13−15 Initially, ACE inhibitors
have been the target of treatment for hypertension and chronic heart failure. The use of ACE inhibitors
in many diseases is due to their vasculoprotective, antiatherogenic, antiinflammatory, antiproliferative, and
antithrombotic effects. 16−18
Complex analytical methods require the use of preseparation processes such as derivatization and extraction in analytical processes. In the pharmaceutical industry, routine quality control laboratories and research
laboratories use methods based on high performance liquid chromatography (HPLC) or hyphenated techniques
in the analysis of mixtures containing more than one active pharmaceutical ingredient. The hyphenated techniques are particularly economically expensive and require skilled analysts, and the optimization of experimental
conditions during analysis is tedious and time-consuming. It is clear that new analytical techniques and methods
are needed to solve complex problems involving two or more active compounds and a sample matrix, which are
economical, fast, and easy to apply and give accurate results. 19 In addition, new techniques in instrumentation
with the help of column technology help to reduce or eliminate the disadvantages of classical and high-tech
combined analytical methods in analytical procedures and to achieve more accurate and more precise analytical
results compared to fully porous particles in conventional columns. In addition to this, it is necessary to select
the temperature and pH stability of the packing material in order to obtain the most effective chromatographic
separation. Some studies with superficially porous particles show that more effective analyses can be made in a
shorter time when these materials are used. 20−25 Particle technology for liquid chromatography has been highly
developed in recent years, and the use of core-shell particles has received great attention in its development. It
1409
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was observed that the solution flow in the columns containing fully porous silica particles was irregular and this
irregularity led to tail spikes and peak expansions in peak shapes. 20−25 However, it has also been reported in the
literature that efficient separations were achieved with stationary phases containing core-shell particles. 20−25
Core-shell particles have sharper peak shapes in a shorter time, rapid column conditioning after the changes in
the mobile phase pH levels, relatively less solvent consumption, and more precise determination. More stable
flow, more stable retention time of peaks, and precision between the results are achieved by superficially porous
particles. 26−30 Thus, rapid analyses can be performed without loss of discrimination. Core-shell particles allow to reduce the mass transfer and to increase the peak efficiency. Along with the improvement in the peak
efficiency, core-shell particle-based columns offer lower flow resistance in HPLC systems, higher resolution, and
shorter analysis times, and sharper peak shapes may occur compared to the fully porous particles. In the
literature, there exists binary determination of AML-PER, PER-IND, or AML-IND using HPLC. 29 Hence, no
literature exists for the simultaneous detection of the ternary mixture using both new generation columns that
have core-shell silica particles and ratio derivative spectrophotometry methods. The proposed study aimed to
develop a more environmentally friendly, rapid, sensitive, and selective method for simultaneous determination
of PER, IND, and AML using new generation HPLC columns. The accuracy and precision of the developed
liquid chromatography method are compared with ratio derivative spectrophotometry by the means of Student
t and F tests.

2. Results and discussion
2.1. Optimization of chromatographic conditions
Prior to the analyses the system was rinsed with the mobile phase. In order to separate PER, AML, and IND
simultaneously, different kinds of columns and varied compositions of the mobile phases were tested. Mobile
phase compositions were evaluated in terms of pH, acetonitrile/methanol/water ratios, and different flow rate
values. Finally, optimum chromatographic separation was achieved using a Kinetex C18 column (150 × 4.6 mm
I.D. 5 µ m) at a flow rate 1.5 mL min −1 with temperature value of 30 ◦ C and 215 nm. With these conditions,
sharp peak shapes and precise retention time values were obtained. The system suitability tests were performed
according to USP 40, 31 < 621 >, and are summarized in Table 1. It can be concluded from the parameters
that the system was found suitable for the simultaneous analyses of PER, AML, and IND.

Table 1. System suitability tests parameters.

Technique
Compounds
Retention time
Capacity factor (k)
Selectivity (α)
Resolution (Rs)
Tailing
Theoretical plate numbers (plate/column)
RSD% of retention time

1410

HPLC
PER
1.33
0.5
1.09
3436
0.120

AML
1.8
1.02
2.07
4.91
1.25
5221
0.220

IND
2.6
1.92
1.88
7.56
0.986
8438
0.180
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2.2. Determination and validation of AML, PER, and IND with DD 1 and chromatographic methods
In two or more compounds’ analyses, the zero-order spectrum did not allow for simultaneous determination due
to the considerable loss of accuracy and sensitivity by overlapping absorbance values. By deciding the wavelengths corresponding to a maximum or minimum of the ratio derivative spectrum, simultaneous determination
can achieve two or more compounds. As shown in Figure 1A, absorption spectra of 4 × 10 −4 M PER, 2 ×
10 −5 M AML, and 1 × 10 −5 M IND in methanol can overlay and cannot achieve simultaneous determination.
When ratio spectra are obtained, as shown in Figure 1B, for 4 × 10 −4 M PER, divided by the mixture of 2
× 10 −5 M IND and 4 × 10 −5 M AML, acceptable results were obtained. Furthermore, 2 × 10 −5 M AML
(divisor is the mixture of 2 × 10 −5 M IND and 8 × 10 −5 M PER) and 1 × 10 −5 M IND (divisor is the
mixture of 4 × 10 −5 M AML and 8 × 10 −5 M PER) were also obtained.
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Figure 1. A) Absorption spectra of a) 4 × 10 −4 M PER, b) 2 × 10 −5 M AML, c) 1 × 10 −5 M IND in methanol; B)
Ratio spectra for a) 4 × 10 −4 M PER, divisor 2 × 10 −5 M IND + 4 × 10 −5 M AML, b) 2 × 10 −5 M AML, divisor
2 × 10 −5 M IND + 8 × 10 −5 M PER, c) 1 × 10 −5 M IND, divisor 4 × 10 −5 M AML + 8 × 10 −5 M PER.

The linear ranges for the first derivative of the ratio spectra method were obtained between 2 × 10 −5 M
and 8 × 10 −4 M for PER at 227.20 nm, 4 × 10 −6 M and 6 × 10 −5 M for AML at 269.40 nm, and 4 × 10 −6
M and 2 × 10 −5 M for IND at 292.00 nm. Using the suggested ratio derivative spectrophotometric method,
PER, AML, and IND were successfully analyzed with LOD values of 4.78 × 10 −7 M, 8.75 × 10 −8 M, and
5.89 × 10 −8 M, respectively (Figure 2A).
The chromatographic method was validated under optimized conditions using the new generation coreshell based Kinetex-C18 column (150 × 4.6 mm I.D. x 5 µ m) at a flow rate of 1.5 mL min −1 at 30

◦

C and

215 nm. As shown in Figure 2B, retention times of PER, AML, and IND were obtained as 1.33 min, 1.80 min,
and 2.60 min, respectively. Linearity ranges were obtained from 1.84 × 10 −6 to 2.76 × 10 −4 for PER, 1.76 ×
10 −6 to 2.11 × 10 −4 for AML, and 2.73 × 10 −6 to 2.73 × 10 −4 for IND. Using this core-shell-based column,
PER, AML, and IND were successfully analyzed with LOD values of 3.04 × 10 −7 M, 1.55 × 10 −7 M, and
1.66 × 10 −7 M, respectively.
LOD, LOQ slope, intercept, standard error of slope, standard error of intercept, and correlation coefficient
values were also calculated. Within-day precision and between-day precision results were given in terms of the
percentage of relative standard deviation (RSD %). All the statistical evaluations are summarized in Table 2.
1411
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1.80
1.76 × 10−6 to
2.11 × 10−4
7 × 106
5.079
0.999
4.6 × 104
5.197
1.55 × 10−7
5.11 × 10−7
0.071
0.214

1.84 × 10−6 to
2.76 × 10−4
3 × 106
–0.133
0.999
3.4 × 104
4.705
3.04 × 10−7
1.00 × 10−6
0.116
0.362

AML

1.33

PER

*Each value is the mean of five experiments.

Slope
Intercept
Correlation coefficient
SE of slope
SE of intercept
Limit of detection (M)
Limit of quantification (M)
Within-day precisiona (RSD%)*
Between-day precisiona (RSD%)*

Linearity range (M)

Retention time (min)/
wavelength (nm)

HPLC

2.73 × 10−6 to
2.73 × 10−4
1.9 × 107
–9.022
0.999
1.8 × 105
16.660
1.66 × 10−7
5.49 × 10−7
0.040
0.157

2.60

IND

2 × 10−5 to
8 × 10−4
344.58
0.0004
0.999
2.68
9.39 × 10−4
4.78 × 10−7
1.45 × 10−6
0.216
0.292

227.20

UV-VIS
PER

4 × 10−6 to
6 × 10−5
2663.90
0.0004
0.999
25.2
7.27 × 10−4
8.75 × 10−8
2.65 × 10−7
0.178
0.347

AML
269.40

Table 2. Statistical evaluation of the calibration data by RP-LC and first derivative of the ratio spectra.

4 × 10−6 to
2 × 10−5
22,029.00
-0.0033
0.999
66.8
6.95 × 10−4
5.89 × 10−8
1.79 × 10−7
0.437
0.399

IND
292.00
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Figure 2. A) First derivative of the ratio spectra for 1) 1 × 10 −4 M, 2) 2 × 10 −4 M, 3) 4 × 10 −4 M PER, divisor
2 × 10 −5 M IND + 4 × 10 −5 M AML; 4) 4 × 10 −6 M, 5) 8 × 10 −6 M, 6) 2 × 10 −5 M AML, divisor 2 × 10 −5
M IND + 8 × 10 −5 M PER; 7) 2 × 10 −6 M, 8) 5 × 10 −6 M, 9) 1 × 10 −5 M IND, divisor 4 × 10 −5 M AML +
8 × 10 −5 M PER. B) Chromatograms for increasing concentrations of 1) 3.68 × 10 −6 M, 2) 9.20 × 10 −6 M, 3) 1.84
× 10 −5 M PER; 1) 3.52 × 10 −6 M, 2) 8.80 × 10 −6 M, 3) 1.76 × 10 −5 M AML; and 1) 5.46 × 10 −6 M, 2) 1.37 ×
10 −5 M, 3) 2.73 × 10 −5 M IND.

2.3. Stability-indicating studies
Forced degradation studies were performed on standard AML, PER, and IND in order to produce the possible
degradation products and their retention behavior by using developed HPLC methodology. For this reason, UV
light (254 nm, 8 h), acid hydrolysis (0.1 M HCl), alkaline hydrolysis (0.1 M NaOH), oxidation (3% H 2 O 2 ) ,
heat in an oven (at 75
−5

◦

C, 8 h), and heat in a water bath (at 75
−5

◦

C, 2 h) stress conditions were applied to

−4

9.20 × 10
M PER, 8.80 × 10
M AML, and 1.37 × 10
M IND. These experiments were conducted and
the resultant peak areas were compared with the untreated constant amount of the standard solutions of each
compound. It was aimed to show that PER, AML, and IND can be analyzed in the presence of their degradants
and the specificity of the developed chromatographic method was adjusted as suggested in the International
Council on Harmonization (ICH) guidelines (Figure 3). Results of stress conditions in terms of degradation
amounts are summarized in Table 3 and calculations were carried out as indicated above.
2.4. Analysis of pharmaceutical dosage form
Coverdine tablets were analyzed, which contain 10.0 mg PER, 5.0 mg AML, and 2.5 mg IND in the presence of
ingredients such as calcium carbonate, 10% pregelatinized maize starch, cellulose microcrystalline, croscarmellose sodium, magnesium stearate, colloidal anhydrous silica, pregelatinized starch, glycerol, hypromellose (6
1413
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Figure 3. Stress degradation conditions for 9.20 × 10 −5 M PER, 8.80 × 10 −5 M AML, and 1.37 × 10 −4 M IND:
A) acidic hydrolysis (0.1 M HCl), B) oxidation (3% H 2 O 2 ) , C) alkaline hydrolysis (0.1 M NaOH), D) heating in oven
(at 75 ◦ C, 8 h), E) UV light (254 nm, 8 h), F) heating in water bath (at 75 ◦ C, 2 h).

Table 3. Results of stress conditions by RP-LC in terms of degradation %.

Conditions
HCl (0.1 M)
NaOH (0.1 M)
H2 O2 (3%)
UV light exposure (8 h at 254 nm)
Oven (8 h at 75 ◦ C)
Water bath (2 h at 70 ◦ C)

PER
5.02
83.75
ND*
13.43
12.7
14.59

AML
4.76
9.66
0.26
0.52
5.02
5.83

IND
1.27
5.60
3.29
4.47
4.55
6.07

*ND: No degradation.

mPa s), macrogol 6000, magnesium stearate, and titanium dioxide. With the proposed chromatographic and
spectrophotometric methods, the Coverdine tablets were successfully analyzed in the presence of the indicated
ingredients (Figure 4). One of the validation parameters, accuracy, was achieved by adding a known amount of
pure drug active compound to Coverdine tablet solutions. For recovery studies reliable results were obtained,
which are in between 96% and 103% recovery levels, as can be seen from Table 4.
2.5. Conclusions
In this work, a separation technique for AML, PER, and IND ternary mixture has been suggested for the first
time based on a new generation column that has superficially porous particles used as a stationary phase in
HPLC and the first derivative ratio spectrophotometric method. Both methods were further compared by using
statistics with F and Student t tests. The results showed that there are no evocative differences between the
methods statistically. Since the run time is only 5 min, the suggested method is rapid and can be used in
1414
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Figure 4. A) Chromatogram of pharmaceutical dosage form Coverdine. B) First derivative of the ratio spectra for
pharmaceutical dosage form Coverdine: a) 7.92 × 10 −5 M PER, divisor 2 × 10 −5 M IND + 4 × 10 −5 M AML,
b) 2.57 × 10 −5 M AML, divisor 2 × 10 −5 M IND + 8 × 10 −5 M PER, c) 2 × 10 −5 M IND, divisor 4 × 10 −5 M
AML + 8 × 10 −5 M PER.

research and development as well as in quality control laboratories where economy is essential. There are no
sophisticated procedures such as extraction or additional cleanup procedures, resulting in an easy and applicable
method. LOD values were obtained as 3.04 × 10 −7 M, 1.55 × 10 −7 M, and 1.66 × 10 −7 M for PER, AML,
and IND, respectively.
In conclusion, liquid chromatographic and spectrophotometric methods were developed and fully validated
according to the ICH guidelines with respect to specificity, linearity, accuracy, and precision. The linearity
ranges, LOD, and LOQ values were better than those of previously suggested methods, showing the power of
the usage of superficially porous silica particles as a stationary phase in HPLC. 26−30

3. Experimental
3.1. Materials and methods
For chromatographic studies, HPLC grade acetonitrile, methanol, orthophosphoric acid, sodium hydroxide,
hydrogen peroxide, and hydrochloric acid were purchased from Sigma Aldrich (Munich, Germany). Methanol
1415
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Table 4. Results of analysis of pharmaceutical dosage forms by RP-LC and first derivative of the ratio spectra.

Technique
Compounds
Labeled claim (M)
Amount found (M)
RSD (%)*
Bias (%)*
t value (t T heo : 2.353)
F value (F T heo : 9.280)
Added (M)
Found (M)*
Recovery (%)
RSD % of recovery*
Bias (%)

HPLC
PER
4.93 ×
4.87 ×
1.02
1.21
0.066
0.102
3.68 ×
3.69 ×
100.45
0.34
–0.45

−5

10
10−5

10−5
10−5

AML
4.83 ×
4.66 ×
0.14
3.51
0.024
0.015
3.52 ×
3.41 ×
97.03
0.15
2.96

−5

10
10−5

10−5
10−5

IND
2.96 ×
3.07 ×
0.14
–4.02
0.039
0.166
8.63 ×
8.61 ×
99.76
0.10
0.23

−5

10
10−5

10−6
10−6

UV-VIS
PER
4.93 × 10−5
4.97 × 10−5
2.03
–0.79
3.0 × 10−5
3.02 × 10−5
100.60
0.81
–0.27

AML
4.83 × 10−5
4.99 × 10−5
0.23
–3.73
1.2 × 10−5
1.20 × 10−5
99.60
0.26
0.12

IND
2.96 × 10−5
2.98 × 10−5
0.43
–1.51
1.0 × 10−5
9.61 × 10−6
96.06
1.36
1.97

*Each value is the mean of five experiments.

(Merck, Darmstadt, Germany) and double distilled water were used for preparing the mobile phase solutions.
PER and IND were from Nobel İlaç Sanayi A.Ş (İstanbul, Turkey), AML was from Sanovel İlaç Sanayi A.Ş
(İstanbul, Turkey), and the commercial brand of ternary mixture Coverdine (PER/AML/IND, 10/5/2.5 mg,
respectively) was obtained from Servier (Dublin, Ireland).

3.2. Equipment
The Agilent 1100 series LC system was used for chromatographic separations equipped with a G1379A degasser,
G1311A quaternary pump, G1313 autoinjector, and G1315B diode array detector. Spectrophotometric experiments were conducted by Shimadzu 1601 PC double beam spectrophotometer equipped with 1.0 cm quartz
cells with a fixed slit width (2 nm), coupled with a computer running Shimadzu UVPC software.

3.3. Chromatographic and spectrophotometric analyses conditions
The separation was carried out at 30 ◦ C and the diode array detector was adjusted to 215 nm using the Kinetex
C18 column (150 × 4.6 mm I.D. 5 µ m) at a flow rate 1.5 mL min −1 . An isocratic mobile phase consisting of a
mixture of acetonitrile and water (40:60, v/v) containing phosphoric acid (0.025%) was used for the simultaneous
separation and analysis of active pharmaceutical ingredients. The spectrophotometric method depends on the
first derivative of the ratio spectra by the division of the absorption spectrum of the ternary mixture by a
standard spectrum of the binary mixture of the components and then calculating the first derivative of the ratio
spectrum. The first derivative of the ratio amplitudes of the ratio spectra were recorded and the values of the
derivatives were measured at suitably selected wavelengths in the range of 200 to 400 nm by plotting against
the corresponding concentrations to obtain the calibration graph at 227.2 nm for PER, 269.4 nm for AML, and
292.0 nm for IND simultaneously. All solutions were protected from light, stored at 4 ◦ C, and used within 24
h to avoid decomposition.

1416
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3.4. Preparation of solutions
Stock solutions of 1 × 10 −3 M AML and IND were prepared in acetonitrile and PER was prepared in methanol.
All solutions were then kept in dark at about 4 ◦ C. Working solutions were prepared daily by the dilution of
these stock solutions using the mobile phase and injected into the HPLC system. Standard solutions of 1 ×
10 −3 M AML, IND, and PER containing concentration ranges between 4 × 10 −6 and 6 × 10 −5 M, 4 ×
10 −6 and 2 × 10 −5 M, and 2 × 10 −5 and 8 × 10 −4 M AML, IND, and PER were prepared in methanol,
respectively.
3.5. Analysis of pharmaceutical dosage form
Ten tablets of Coverdine were accurately weighed, crushed, and finely powdered in a mortar. From this powder,
the weight of the powder equivalent to one tablet’s content was accurately weighed, transferred to a 100 mL
calibrated flask, diluted with acetonitrile, sonicated about 10 min, and then completed to total volume with
acetonitrile for HPLC study. For UV spectroscopy analysis, one tablet’s content was accurately weighed,
transferred to a 50 mL calibrated flask, diluted with methanol, sonicated about 10 min, and then completed to
total volume with methanol. The pharmaceutical dosage form solutions were prepared related to a composition
of solution that contained 10.0 mg, 5.0 mg, and 2.5 mg, PER, AML, and IND, respectively.
3.6. System suitability and validation of the method
According to ICH guidelines, the suitably of the system should be proven related to some parameters such as
capacity factor ( k) , selectivity ( α) , resolution (R s ), tailing, and theoretical plate numbers (N). 32−35 After the
system suitability was established based on the acceptability criteria, validation of the suggested methods was
performed in terms of linearity, LOD and LOQ, precision, accuracy, etc. Linear ranges for the PER, AML,
and IND were obtained separately, while limit of detection (LOD = 3.3 s/m) and limit of quantification (LOQ
=10 s/m) were calculated using the standard deviation of response (s) and the slope (m) of the calibration
curve. For the spectrophotometric method, the first derivative of the ratio spectra by division of the absorption
spectrum of the ternary mixture by a standard spectrum of binary mixture of the components method (DD 1 )
was used. The first derivative of the ratio amplitudes at 227.2 nm for PER, 269.4 nm for AML, and 292.0 nm
for IND were selected simultaneously. 31−35 Within the scope of the validation studies, recovery studies were
also performed to demonstrate the applicability of the methods by adding a known pure amount of drug to the
pharmaceutical dosage form. Recovery data were statistically compared with each method using the Student
t and variance ratio F tests. In both tests, the calculated values did not exceed the theoretical values, which
underlined that there were no significant differences between the recoveries from the HPLC and derivative-UV
methods.
Moreover, degradation studies were accompanied with stress conditions as suggested in the ICH guidelines,
such as UV light (254 nm, 8 h), acidic hydrolysis (0.1 M HCl), alkaline hydrolysis (0.1 M NaOH), oxidation
(3% H 2 O 2 ) , and heat in an oven (at 75

◦

C, 8 h), to assess the stability of the chromatographic method. The

−4

stock solutions of 9.2 × 10
M PER, 8.8 × 10 −4 M AML, and 1.37 × 10 −3 M IND were used in these
studies. Based on the results, there were no strong signs of degradation of all compounds observed in acidic
conditions. Contrary to acidic conditions, in basic media not only was PER extremely degraded by about
83.75%, but AML and IND were also affected by this condition. The situation was quite different in the case of
oxidative treatment: nearly no degradation products occurred for PER and AML. In the case of IND, only 3.3%
1417
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degradation was determined. Not only the heating of the solid form but also the solution in water bath affected
production of degradation peaks. In both conditions, degradation appeared within the range of 4.55%–12.7%
and 5.83%–14.59% for heating the solid form in an oven and heating the solution in a water bath, respectively.
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